Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease
Molecular Pharmacology - United States
doi 10.1124/mol.118.114348
Full Text
Open PDFAbstract
Available in full text
Date
January 29, 2019
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)